← Browse by Condition
Medical Condition
depressive disorder
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for depressive disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — depressive disorder Clinical Trials
How many clinical trials are currently recruiting for depressive disorder?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for depressive disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for depressive disorder?
depressive disorder research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a depressive disorder clinical trial?
Eligibility criteria for depressive disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06901739
Recruiting
Enrollment
120 pts
Location
Spain
Sponsor
Celia Bañuls
NCT05388461
Recruiting
Enrollment
600 pts
Location
Norway
Sponsor
Haukeland University Hospital
NCT07197138
Recruiting
Enrollment
42 pts
Location
Germany
Sponsor
Max-Planck-Institute of Psychi...
NCT07290153
Recruiting
Enrollment
120 pts
Location
China
Sponsor
Fudan University
NCT06844058
Recruiting
Enrollment
90 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul Nisantasi University
NCT05786066 Phase 2
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
Yale University
NCT06408012
Recruiting
Enrollment
2,200 pts
Location
Canada
Sponsor
St. Joseph's Healthcare Hamilt...
NCT07903246
Recruiting
Enrollment
2,690 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
NCT07252427
Recruiting
Enrollment
120 pts
Location
China
Sponsor
Fang Tang
NCT06072898 Phase 2
Recruiting
Enrollment
50 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
NCT06733883
Recruiting
Enrollment
20 pts
Location
Norway
Sponsor
Oslo University Hospital
Related Conditions
anxiety disorders (2) major depressive disorder (2) obese patients bmi 30 kg m (1) anxiety (1) post acute covid 19 syndrome (1) breast cancer female nos (1) general anxiety disorder (1) bipolar disorder (1) post traumatic stress disorder (1) suicidal ideation (1) mood disorders (1) bipolar and related disorders (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology